trending Market Intelligence /marketintelligence/en/news-insights/trending/k_mfmzl2oiiooyv9mg180q2 content esgSubNav
In This List

LGC acquires Seracare Life Sciences

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


LGC acquires Seracare Life Sciences

LGC Ltd. acquired SeraCare Life Sciences Inc., a manufacturer of diagnostic products and biological materials for clinical laboratories and researchers worldwide.

SeraCare provides control materials for infectious disease testing along with clinical next-generation sequencing products.

Teddington, U.K.-based LGC will strengthen its position in the clinical quality control tools market through this acquisition. SeraCare employs 170 people and will continue to operate from its two sites in Milford, Mass., and Gaithersburg, Md., under LGC.

LGC is an international company in the extended life sciences sector, including human healthcare, agri-food and the environment and has 2600 employees operating out of 19 countries worldwide.